Evaluating the Safety and Tolerability of Etravirine in HIV-1 Infected Infants and Children
Clinical trial NCT01504841 · COMPLETED
Trial details
- NCT number
- NCT01504841
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-14
- Primary completion
- 2018-07-17
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.